{"name": "InDex Pharmaceuticals",
 "permalink": "index-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/index-pharmaceuticals",
 "homepage_url": "http://www.indexpharmab.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "46-8-508-847-30",
 "description": "",
 "created_at": "Sat Jan 22 09:00:11 UTC 2011",
 "updated_at": "Sat Jan 22 09:05:30 UTC 2011",
 "overview": "\u003Cp\u003EInDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       63],
      "assets/images/resized/0011/8522/118522v1-max-150x150.jpg"],
     [[198,
       84],
      "assets/images/resized/0011/8522/118522v1-max-250x250.jpg"],
     [[198,
       84],
      "assets/images/resized/0011/8522/118522v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "kr75M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/01/index-pharmaceuticals-raises-sek75m.html",
    "source_description": "InDex Pharmaceuticals Raises SEK75M",
    "raised_amount": 75000000.0,
    "raised_currency_code": "SEK",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Industrifonden",
         "permalink": "industrifonden",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0003/2833/32833v1-max-150x150.png"],
             [[241,
               44],
              "assets/images/resized/0003/2833/32833v1-max-250x250.png"],
             [[241,
               44],
              "assets/images/resized/0003/2833/32833v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SEB Venture Capital",
         "permalink": "seb-venture-capital",
         "image":
          {"available_sizes":
            [[[100,
               70],
              "assets/images/resized/0002/9960/29960v1-max-150x150.png"],
             [[100,
               70],
              "assets/images/resized/0002/9960/29960v1-max-250x250.png"],
             [[100,
               70],
              "assets/images/resized/0002/9960/29960v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Scheeles v\u00c3\u00a4g 2",
    "address2": "",
    "zip_code": "SE-171 77",
    "city": "Stockholm",
    "state_code": null,
    "country_code": "SWE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        92],
       "assets/images/resized/0011/8523/118523v1-max-150x150.jpg"],
      [[250,
        154],
       "assets/images/resized/0011/8523/118523v1-max-250x250.jpg"],
      [[450,
        278],
       "assets/images/resized/0011/8523/118523v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}